Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications-Reference-Cited by-同舟云学术

Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications

Published:1982-11 Issue:11 Volume:18 Page:1069-1074
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Vermorken J.B.,Van Der Vijgh W.J.F.,Klein I.,Gall H.E.,Pinedo H.M.

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Cisplatin (cis-diammine-dichloroplatinum II);Prestayko;Cancer Treat Rev,1979

2. Cis-diamminedichloroplatinum (II): a metal complex with significant anticancer activity;Von Hoff;Adv Pharmacol Chemother,1979

3. Cisplatin;Rozencweig,1979

4. 24-Hour infusion of cisplatinum in head and neck cancer;Jacobs;Cancer,1978

5. Further studies with cis-diamminedichloroplatinum by 5-day continuous infusion;Salem,1980

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer;Cancer Chemotherapy and Pharmacology;2023-03

2. Treatment Intensification in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: What Are the Options and for Whom?;Critical Issues in Head and Neck Oncology;2023

3. Alkylating Agents and Platinum Antitumor Compounds;Holland‐Frei Cancer Medicine;2022-10-21

4. Revisiting EXTREME in the Immuno-Oncology Era: How to Improve Its Outcomes;The Oncologist;2021-09-28

5. Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice;Frontiers in Oncology;2019-06-11